Crossject S.A.
$1.86▼ 1.06%($-0.02)
TickerSpark Score
43/100
▌ Weak
27
Valuation
40
Profitability
55
Growth
64
Health
30
Momentum
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ALCJ.PA research report →
52-Week Range38% of range
Low
$1.35
Current
$1.86
High
$2.69
Company Overviewwww.crossject.com
About the company
Crossject S. A. is dedicated to pioneering needle-free drug delivery solutions.
- CEO
- Patrick Alexandre
- IPO
- 2014
- Employees
- 112
- HQ
- Dijon, FR
Price Chart
+21.57% · this period
Valuation
- Market Cap
- $111.02M
- P/E
- -8.99
- P/S
- 74.86
- P/B
- -19.95
- EV/EBITDA
- 35.02
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -329.74%
- Op Margin
- -78.15%
- Net Margin
- -699.06%
- ROE
- 299.54%
- ROIC
- -3.82%
Growth & Income
- Revenue
- $0 · -100.00%
- Net Income
- $-10,367,000 · 18.98%
- EPS
- $-0.20 · 28.57%
- Op Income
- $-12,096,000
- FCF YoY
- 5.54%
Performance & Tape
- 52W High
- $2.69
- 52W Low
- $1.35
- 50D MA
- $2.01
- 200D MA
- $2.10
- Beta
- 0.50
- Avg Volume
- 339.91K
Get TickerSpark's AI analysis on ALCJ.PA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Coverage · ALCJ.PA
Our ALCJ.PA coverage
Recent articles, reports, and earnings notes.
On-Demand Research
No research on ALCJ.PA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ALCJ.PA report →Internal Compare
Similar companies
Peers in the same neighborhood.